Cargando…

Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results

Detalles Bibliográficos
Autores principales:	Zhou, Yitian, Lauschke, Volker M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816843/ https://www.ncbi.nlm.nih.gov/pubmed/36618803 http://dx.doi.org/10.21037/atm-2022-70

Ejemplares similares

SLCO1B1 Polymorphisms and Statin-Induced Myopathy
por: Stewart, Alison
Publicado: (2013)

Should We Prescribe More Protein to Critically Ill Patients?
por: Heyland, Daren K., et al.
Publicado: (2018)

Statin treatment effectiveness and the SLCO1B1*5 reduced function genotype: Long‐term outcomes in women and men
por: Türkmen, Deniz, et al.
Publicado: (2022)

SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort
por: Magavern, Emma F., et al.
Publicado: (2023)

A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy
por: Turongkaravee, Saowalak, et al.
Publicado: (2021)

Debate: Should statin be used in patients with heart failure?
por: Pietro Maggioni, Aldo
Publicado: (2001)

Debate: Statins should be used in patients with heart failure
por: Kjekshus, John
Publicado: (2001)

Zika virus in the testes: should we be worried?
por: Wong, Gary, et al.
Publicado: (2017)

Brugada syndrome: should we be screening patients before prescribing psychotropic medication?
por: Attard, Azizah, et al.
Publicado: (2022)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

Evidence should inform more than prescribing decisions
por: Cowdell, Fiona
Publicado: (2022)

Health promotion for children, mothers and families: here’s why we should “think about it before conception”
por: Corchia, Carlo, et al.
Publicado: (2013)

A Cost–Consequence Analysis of Preemptive SLCO1B1 Testing for Statin Myopathy Risk Compared to Usual Care
por: Brunette, Charles A., et al.
Publicado: (2021)

SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population
por: Hubáček, Jaroslav A., et al.
Publicado: (2015)

Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant
por: Merkel, Melissa, et al.
Publicado: (2021)

SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
por: Sortica, Vinicius A, et al.
Publicado: (2017)

Should we modulate the neonatal microbiome and what should be the goal?
por: van Best, Niels, et al.
Publicado: (2022)

Should We Tip Our CAPs to Statins?
por: Simpson, A. John, et al.
Publicado: (2019)

Should We Have a Universal 1-Week Lockdown Every Year?
por: Alpert, Joseph S., et al.
Publicado: (2020)

Should we abandon manual muscle strength testing in the ICU?
por: Hermans, Greet, et al.
Publicado: (2011)

Commentary: Why we should report results from clinical trial pilot studies
por: Friedman, Lawrence
Publicado: (2013)

Should we breathe quiet or noisy?
por: Putensen, Christian, et al.
Publicado: (2014)

Leadership in nursing: why should we discuss it?
por: Cassiani, Silvia Helena de Bortoli, et al.
Publicado: (2019)

Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
por: Garpestad, Erik, et al.
Publicado: (2006)

Understanding environmental influences on nutrition and physical activity behaviors: where should we look and what should we count?
por: Ball, Kylie, et al.
Publicado: (2006)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

Should we go nuts about nuts?
por: Rohrmann, Sabine, et al.
Publicado: (2013)

How should we address the pipeline problem?
por: Braun, Hillary J.
Publicado: (2016)

Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations
por: Nagy, Agnes, et al.
Publicado: (2015)

Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users
por: Jansen, Marleen E., et al.
Publicado: (2023)

A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance
por: Bigossi, Margherita, et al.
Publicado: (2023)

Why are we fat? Discussions on the socioeconomic dimensions and responses to obesity
por: Rayner, Geof, et al.
Publicado: (2010)

Vaccine safety concerns: Should we be changing the way we support immunization?
por: MacDonald, Noni E, et al.
Publicado: (2020)

Commentary: Just because we can, doesn't always mean we should
por: Nellis, Joseph R., et al.
Publicado: (2021)

Statins, bone, and neurofibromatosis type 1
por: Korf, Bruce R
Publicado: (2008)

Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
por: Song, Gonjin, et al.
Publicado: (2021)

Debate: Unstable angina - When should we intervene?
por: Kereiakes, Dean J
Publicado: (2000)

Novel Forms of Lipodystrophy: Why should we care?
por: Rother, Kristina I., et al.
Publicado: (2013)

Endotracheal tube leak: What should we do?
por: Gupta, Nishkarsh
Publicado: (2015)

NSTEMI treatment: should we always follow the guidelines?
por: van ’t Hof, A. W. J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fck3sgft2pa7i8spclldjj1pg5